Cano Health Inc. (NYSE:CANO) finished Wednesday with a subtraction of -$0.04 to close at $6.31, a downside of -0.63 percent. An average of 2,870,960 shares of common stock have been traded in the last five days. There was a fall of -$0.71 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 3,468,430 shares traded, while the 50-day average volume stands at 3,529,004.
CANO stock has increased by 13.69% in the last month. The company shares reached their 1-month lowest point of $4.95 on 08/22/22. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $3.81 and a high of $15.12 in 52 weeks. It has reached a new high 1 time so far this year and lost -29.18% or -$2.60 in price. In spite of this, the price is down -58.27% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Cano Health Inc. (CANO) has a trailing price-to-sales (P/S) ratio at 1.39, the price-to-book (PB) ratio at 3.22.
Further, the company has a long term debt to equity ratio of 2.23 and a total debt to equity ratio of 2.25 for the quarter ending March 30. Its gross profit as reported stood at $1.74 billion compared to revenue of $1.61 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Cano Health Inc.’s return on assets was -1.50%.
For the three-month period that ended March 30, Cano Health Inc. had $914.89 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$5.33 million in the quarter, while revenues were grew 277.86%. The analyst consensus anticipated Cano Health Inc.’s latest quarter earnings to come in at -$0.07 per share, but it turned out to be $0, a 100.00% surprise. For the quarter, EBITDA amounted to -$10.39 million. Shareholders own equity worth $485.89 million.
From a technical analysis perspective, let’s take a brief look at Cano Health Inc. (CANO) price momentum. RSI 9-day as of the close on 21 September was 46.94%, suggesting the stock is Neutral, with historical volatility in this time frame at 82.31%.
As of today, CANO’s price is $6.57 -10.11% or -$0.71 from its 5-day moving average. CANO is currently trading +4.47% higher than its 20-day SMA and +13.49% higher than its 100-day SMA. However, the stock’s current price level is +16.21% above the SMA50 and -25.33% below the SMA200.
The stochastic %K and %D were 36.72% and 45.01%, respectively, and the average true range (ATR) was 0.46. With the 14-day stochastic at 31.64% and the average true range at 0.46, the RSI (14) stands at 50.27%. The stock has reached -0.24 on the 9-day MACD Oscillator while the 14-day reading was at -0.06.
Truist launched coverage on Cano Health Inc. (NYSE: CANO) in its analyst report released on September 07, 2022. The firm assigned the stock a Hold rating. The consensus rating for Cano Health Inc. (CANO) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell CANO, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 6 others rate it as a “buy”.
What is CANO’s price target for the next 12 months?
Analysts predict a range of price targets between $4.00 and $12.00, with a median target of $8.00. Taking a look at these predictions, the average price target given by analysts for Cano Health Inc. (CANO) stock is $8.54.